Implications of Maple Syrup Urine Disease in Newborns

Nurs Womens Health. 2017 Jun-Jul;21(3):196-206. doi: 10.1016/j.nwh.2017.04.009.

Abstract

Maple syrup urine disease (MSUD) is an inherited metabolic disorder that affects the body's ability to metabolize amino acids. If left untreated, it places newborns at risk for life-threatening health problems, including episodes of illness called metabolic crisis. Newborn screening for MSUD should ideally be done within the first 24 to 48 hours after birth. With proper screening, along with genetic counseling, nutritional counseling, primary care follow-up, and ongoing monitoring, newborns with MSUD can typically go on to live healthful lives. Nurses play a key role in supporting families with a diagnosis of MSUD.

Keywords: genetic testing; maple syrup urine disease; metabolic disorders; newborn screening.

MeSH terms

  • Amino Acids, Branched-Chain / blood
  • Feeding and Eating Disorders / physiopathology
  • Humans
  • Infant, Newborn
  • Maple Syrup Urine Disease / diagnosis*
  • Maple Syrup Urine Disease / physiopathology*
  • Maple Syrup Urine Disease / therapy
  • Neonatal Screening / methods*
  • Urine / chemistry
  • Vomiting / physiopathology
  • Weight Loss / physiology

Substances

  • Amino Acids, Branched-Chain